Tilray Brands, Inc. (TLRY)

Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets

BrewDog Acquisition Boosts Tilray's Q1 Performance

Tilray Q1: Not Looking Good, Remains A 'Hold'

3 Huge Red Flags From Tilray's Q1 Earnings Report

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

3 Reasons I'm Still Not Buying Tilray Stock -- Even at Penny-Stock Prices

Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform

Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript

Tilray Brands Q1 Earnings Call Highlights

Tilray revenue rises as beverage business drives record quarterly sales

Tilray Brands Not Dependent on Single Market, CEO Highlights Multiple Growth Engines

Tilray Brands Sinks 4% as Record Revenue Masks Shrinking Cannabis Sales; Canopy Growth and Aurora Cannabis Ease

Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Misses Revenue Estimates

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution

Tilray Brands stock analysis ahead of earnings: will it rebound or fall further?

BrewDog's Winning Streak Rolls on with Gold at the Scottish Beer Awards

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation

Tilray Brands: Is the Stock a Buy at Less Than $4?

TherapeuticsMD (NASDAQ:TXMD) and Tilray Brands (NASDAQ:TLRY) Financial Review